# Synthesis and antitumor activity of mono and digold(i) alkynyl complexes with oligo(ethylene glycol)methylether

**Authors:** Yanyan Zeng, Fei Zheng, Lingyu Jin, Qiu Mei Chen, Ping Zhou, Xiaoqing Mou, Xiang Hua Wu, Jun Feng Zhang, Wen Xiu Ren

PMC · DOI: 10.1039/d5ra08951d · RSC Advances · 2026-02-03

## TL;DR

Researchers synthesized new gold complexes with antitumor properties, finding that some were especially effective at killing cancer cells by inhibiting a key enzyme.

## Contribution

The paper introduces novel alkynyl gold(i) complexes with tunable antitumor activity and identifies their mechanism of action via TrxR inhibition.

## Key findings

- AuPPh3 complexes showed better cytotoxicity than dppfAu2 complexes against A549 and HeLa cells.
- Complex 4-(OCH2CH2OCH2CH2OCH3)C6H4CAuPPh3 (1d) strongly inhibited thioredoxin reductase (TrxR).
- Modifications to gold centers and ligands fine-tuned the in vitro antitumor activity.

## Abstract

Preparation and characterization of a series of oligo(ethylene glycol)methylether functionalized alkynyl gold(i) complexes capped with AuPPh3 (1a–1d) or dppfAu2 (dppf, 1,1′-bis(diphenyphosphino)ferrocene) (2a–2d) have been accomplished. The structures of 1b and 1c were established by X-ray crystallography. Their in vitro antitumor activities were measured by the CCK8 method against A549 and HeLa cells. The studies indicated that the cytotoxic activity in vitro was fine-tuned by modification of both the gold(i) centers and the oligo(ethylene glycol)methylether ancillary ligands. Compared to the dppfAu2 series, the AuPPh3 series showed better cytotoxicity. Especially, complex 4-(OCH2CH2OCH2CH2OCH3)C6H4C

<svg xmlns="http://www.w3.org/2000/svg" version="1.0" width="23.636364pt" height="16.000000pt" viewBox="0 0 23.636364 16.000000" preserveAspectRatio="xMidYMid meet"><metadata>
Created by potrace 1.16, written by Peter Selinger 2001-2019
</metadata><g transform="translate(1.000000,15.000000) scale(0.015909,-0.015909)" fill="currentColor" stroke="none"><path d="M80 600 l0 -40 600 0 600 0 0 40 0 40 -600 0 -600 0 0 -40z M80 440 l0 -40 600 0 600 0 0 40 0 40 -600 0 -600 0 0 -40z M80 280 l0 -40 600 0 600 0 0 40 0 40 -600 0 -600 0 0 -40z"/></g></svg>


CAuPPh3 (1d) displayed strong anticancer activity toward both cancer cells due to the strong inhibition of thioredoxin reductase (TrxR).

In this paper, novel oligo(ethylene glycol)methylether functionalized alkynyl gold(i) complexes capped with AuPPh3 or dppfAu2 were synthesized. The AuPPh3 series showed better cytotoxicity and were powerful inhibitors of TrxR.

## Linked entities

- **Proteins:** trxR (F420-dependent thioredoxin reductase)
- **Chemicals:** gold (PubChem CID 23985)

## Full-text entities

- **Genes:** PRDX5 (peroxiredoxin 5) [NCBI Gene 25824] {aka ACR1, AOEB166, B166, HEL-S-55, PLP, PMP20}
- **Diseases:** cytotoxic (MESH:D064420), cancer (MESH:D009369)
- **Chemicals:** 1,1'-bis(diphenyphosphino)ferrocene (-), dppf (MESH:C519379), CCK8 (MESH:D012844)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12865784/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12865784/full.md

## References

29 references — full list in the complete paper: https://tomesphere.com/paper/PMC12865784/full.md

---
Source: https://tomesphere.com/paper/PMC12865784